Trends in outcomes of women with myocardial infarction
undergoing primary angioplasty-Analysis of randomized trials

ENPřihlásit se Přihlásit se (EduID)

Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of ...

Přehled o publikaci

J 2023

Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials

MOTOVSKA, Zuzana; Ota HLINOMAZ; Michael ASCHERMANN; Jiří JARKOVSKÝ; Michael ZELIZKO et. al.

Základní údaje

Originální název

Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials

Autoři

MOTOVSKA, Zuzana; Ota HLINOMAZ; Michael ASCHERMANN; Jiří JARKOVSKÝ; Michael ZELIZKO; Petr KALA; Ladislav GROCH; Michal SVOBODA; Milan HROMADKA a Petr WIDIMSKY

Vydání

Frontiers in Cardiovascular Medicine, Lausanne, Frontiers, 2023, 2297-055X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Organizace

Lékařská fakulta – Masarykova univerzita – Repozitář

DOI

http://dx.doi.org/10.3389/fcvm.2022.953567

UT WoS

000913324400001

EID Scopus

2-s2.0-85146448325

Klíčová slova anglicky

myocardial infarction; primary PCI; women; outcome; trends; mortality; therapy management

Návaznosti

LX22NPO5104, projekt VaV. CZECRIN IV, velká výzkumná infrastruktura.

Změněno: 26. 1. 2024 03:45, RNDr. Daniel Jakubík

Anotace

V originále

lt; 0.001). The risk of 30-day mortality decreased by 61% (0.39 [0.17-0.91], p = 0.029). ConclusionThe prognosis of women with MI treated with primary PCI improved substantially with 24/7 regional availability of mechanical reperfusion, performance-enhancing technical progress, and intensive adjuvant antithrombotic therapy. A major modifiable hindrance to achieving this benefit in a broad population of women is the timely diagnosis by health professional services.

Přiložené soubory

https://is.muni.cz/publication/2278220/Trends_in_outcomes_of_women_with_myocardial_infarction_undergoing_primary_angioplasty_-_Analysis_of_randomized_trials.pdf

Citovat

MOTOVSKA, Zuzana; Ota HLINOMAZ; Michael ASCHERMANN; Jiří JARKOVSKÝ; Michael ZELIZKO; Petr KALA; Ladislav GROCH; Michal SVOBODA; Milan HROMADKA a Petr WIDIMSKY. Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials. Frontiers in Cardiovascular Medicine. Lausanne: Frontiers, 2023, roč. 9, January 2023, s. 1-11. ISSN 2297-055X. Dostupné z: https://dx.doi.org/10.3389/fcvm.2022.953567.

@article{55749,
   author = {Motovska, Zuzana and Hlinomaz, Ota and Aschermann, Michael and Jarkovský, Jiří and Zelizko, Michael and Kala, Petr and Groch, Ladislav and Svoboda, Michal and Hromadka, Milan and Widimsky, Petr},
   article_location = {Lausanne},
   article_number = {January 2023},
   doi = {http://dx.doi.org/10.3389/fcvm.2022.953567},
   keywords = {myocardial infarction; primary PCI; women; outcome; trends; mortality; therapy management},
   language = {eng},
   issn = {2297-055X},
   journal = {Frontiers in Cardiovascular Medicine},
   title = {Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials},
   url = {https://www.frontiersin.org/articles/10.3389/fcvm.2022.953567/full},
   volume = {9},
   year = {2023}
}

TY  - JOUR
ID  - 55749
AU  - Motovska, Zuzana - Hlinomaz, Ota - Aschermann, Michael - Jarkovský, Jiří - Zelizko, Michael - Kala, Petr - Groch, Ladislav - Svoboda, Michal - Hromadka, Milan - Widimsky, Petr
PY  - 2023
TI  - Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials
JF  - Frontiers in Cardiovascular Medicine
VL  - 9
IS  - January 2023
SP  - 1-11
EP  - 1-11
PB  - Frontiers
SN  - 2297-055X
KW  - myocardial infarction
KW  - primary PCI
KW  - women
KW  - outcome
KW  - trends
KW  - mortality
KW  - therapy management
UR  - https://www.frontiersin.org/articles/10.3389/fcvm.2022.953567/full
N2  - lt; 0.001). The risk of 30-day mortality decreased by 61% (0.39 [0.17-0.91], p = 0.029). ConclusionThe prognosis of women with MI treated with primary PCI improved substantially with 24/7 regional availability of mechanical reperfusion, performance-enhancing technical progress, and intensive adjuvant antithrombotic therapy. A major modifiable hindrance to achieving this benefit in a broad population of women is the timely diagnosis by health professional services.
ER  -

MOTOVSKA, Zuzana; Ota HLINOMAZ; Michael ASCHERMANN; Jiří JARKOVSKÝ; Michael ZELIZKO; Petr KALA; Ladislav GROCH; Michal SVOBODA; Milan HROMADKA a Petr WIDIMSKY. Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials. \textit{Frontiers in Cardiovascular Medicine}. Lausanne: Frontiers, 2023, roč.~9, January 2023, s.~1-11. ISSN~2297-055X. Dostupné z: https://dx.doi.org/10.3389/fcvm.2022.953567.